| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 09/12/2006 | US7105675 Analgesics with use of treating pain and as immunomodulators and for treatment of drug dependence |
| 09/12/2006 | US7105674 A pigment preparation comprising at least one organic perylene pigment, and at least one perylene derivative, one or more rosins |
| 09/12/2006 | US7105673 Cardioprotective phosphonates and malonates |
| 09/12/2006 | US7105667 Fused heterocyclic compounds and use thereof |
| 09/12/2006 | US7105531 Tricyclic protein kinase inhibitors |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105526 Benzimidazole derivatives |
| 09/12/2006 | US7105524 2-(3,4,4-Trifluoro-but-3-enylsulfanyl)-thiazolo[5,4-b]pyridine; treating, controlling warm-blooded animals, fish and humans against infestation and infection by nematodes, helminths, arachnids and arthropod endo- and ectoparasites. |
| 09/12/2006 | US7105509 Benzodiazepine derivatives as APP modulators |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105492 Antitumor agents |
| 09/12/2006 | US7105471 Arylphenyl-substituted cyclic ketoenols |
| 09/12/2006 | CA2167004C Agent for treating mental disorders associated with cerebrovascular disorders |
| 09/08/2006 | WO2006093719A1 An efficient and stereoselective process for large scale synthesis of 3-(r)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-b}quinolin-9-one |
| 09/08/2006 | WO2006092731A1 1, 2, 4-triazole derivatives and their use as oxytocin antagonists |
| 09/07/2006 | US20060199961 Method of manufacturing of 7-ethyl-10-[4-(1-piperidino)-1- piperidino]- carbonyloxy- camptothecin |
| 09/07/2006 | US20060199956 Bicyclic heterocycles as HIV integrase inhibitors |
| 09/07/2006 | US20060199954 non-yellow color, purity antibiotics; reacting with chlorotrimethylsilane to yield 31,42-bis-trimethylsilyl ether, heptane solvent extraction, and de-protection with sulfuric acid |
| 09/07/2006 | US20060199848 Ion channel modulating activity II |
| 09/07/2006 | US20060199834 Prepared by dissolving 42-O-(2-hydroxy)ethyl-rapamycin in a solution containing an organic solvent and an aqueous buffer having a pH of 4 to 10; and extracting the SDZ-RAD Isomer C into an organic solvent; immunosuppressive, anti-inflammatory, antifungal, antiproliferative and antitumor agents |
| 09/07/2006 | US20060199833 Novel chemiluminescent compounds and their use |
| 09/07/2006 | US20060199815 NK1 antagonists |
| 09/07/2006 | US20060199814 Chemical Intermediate |
| 09/07/2006 | US20060199794 avoid the adverse side effects associated with non-selective receptor interactions; 1-(4-Fluorobenzyl)-2-(4-methoxybenzyl)-8-methyl-1,2,8-triaza-spiro[4.5]decan-3-one; 1-oxa-4,9-diaza-spiro[5.5]undecan-3-one compounds as monoamine receptor modulators; schizophrenia, psychosis, migraine, hypertension |
| 09/07/2006 | US20060199253 Concentrating the mother liquor; subjecting rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid obtained by concentrating the mother liquor to treatment with a pH adjusting buffer; subjecting the mixture to solvent extraction; drying, recrystallization |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698375A1 Azetidine ring compounds and drugs comprising the same |
| 09/06/2006 | EP1697382A2 Rifamycin analogs and uses thereof |
| 09/06/2006 | EP1697380A1 The method of manufacturing of 7-ethyl-10-hydroxycamptothecin |
| 09/06/2006 | EP1697379A1 Spirocyclic cyclohexane derivatives |
| 09/06/2006 | EP1697357A2 Tricyclic benzimidazoles |
| 09/06/2006 | EP1697321A1 2-halogen-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives |
| 09/06/2006 | EP1696921A1 Tricyclic imidazopyridines for use as gastric secretion inhibitors |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/06/2006 | EP1409490B1 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta a|naphthalenyl derivatives with antipsychotic activity |
| 09/06/2006 | EP1326632B1 Proteasome inhibitors for the treatment of hepatitis virus infections |
| 09/06/2006 | CN1829749A Vinyl monomer and polymer derived from the monomer, and light emitting device using the polymer |
| 09/06/2006 | CN1827621A Novel derivatives and analogues of galanthamin |
| 09/06/2006 | CN1273476C Oligonucleotide analoguse |
| 09/05/2006 | US7101903 9-(4-Methylbenzyl)-6-[4-(trifluoromethoxy)phenyl]-1,9-dihydropyrano[3,4-b]indole-3,4-dione; treating fibrinolytic disorders, vein thrombosis and coronary heart disease, and pulmonary fibrosis |
| 09/05/2006 | US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 09/05/2006 | US7101890 Benzazepine derivatives, drugs containing these and use of the same for producing drugs |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 09/05/2006 | US7101875 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases |
| 09/05/2006 | US7101871 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/05/2006 | US7101867 Benzofuran derivatives, their production and use |
| 09/05/2006 | US7101533 Agent for inducing receptor potential |
| 09/05/2006 | US7101428 stability of gamma-quinacridone pigment during milling by addition of 2,9-dichloroquinacridone |
| 08/31/2006 | WO2006091800A2 Novel pyridine derivatives as potassium ion channel openers |
| 08/31/2006 | WO2006091246A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 08/31/2006 | WO2006090699A1 Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion |
| 08/31/2006 | WO2006089657A1 New synthesis of a camptothecin subunit |
| 08/31/2006 | WO2006089633A2 Spiroketal-substituted cyclic ketoenols |
| 08/31/2006 | WO2006089406A1 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents |
| 08/31/2006 | WO2006066896A3 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 08/31/2006 | WO2006065711A3 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 08/31/2006 | WO2006050965A8 Pyrimidine compounds as histamine modulators |
| 08/31/2006 | WO2006026368A3 Development of fluorogenic substrates for monoamine oxidases (mao-a and mao-b) |
| 08/31/2006 | US20060194968 Cyclic benizimidazoles |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194827 5-Cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds |
| 08/31/2006 | US20060194803 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 08/31/2006 | US20060194787 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 08/31/2006 | US20060194294 Process for the recovery of staurosporine from a fermentation broth |
| 08/31/2006 | US20060192473 Organic electroluminescent device |
| 08/31/2006 | DE102005009099A1 New camptothecin-peptide derivatives, useful for treating cancer |
| 08/31/2006 | CA2752738A1 Small molecule inhibitors of mdm2 and uses thereof |
| 08/31/2006 | CA2633940A1 Preventive or therapeutic agent for cardiac dysfunction or myocardial injury caused by ischemia or ischemia reperfusion |
| 08/31/2006 | CA2599164A1 Novel pyridine derivatives as potassium ion channel openers |
| 08/31/2006 | CA2597777A1 Spiroketal-substituted cyclic ketoenols |
| 08/31/2006 | CA2597388A1 New synthesis of a camptothecin subunit |
| 08/31/2006 | CA2586080A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 08/30/2006 | EP1695977A2 Spiro [isobenzofuran-1,4'piperidin]-3-ones and 3H-spiroisobenzofuran-1, 4'-piperidines |
| 08/30/2006 | EP1694799A2 Process for upgrading naphtha |
| 08/30/2006 | EP1694684A1 Process for making camptothecin derivatives |
| 08/30/2006 | EP1694653A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 08/30/2006 | EP1487813B1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 08/30/2006 | EP1421086B1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA a|NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY |
| 08/30/2006 | EP1383772B1 Nitrogen-based camptothecin derivatives |
| 08/30/2006 | EP1318811B1 Cyclopentyl modulators of chemokine receptor activity |
| 08/30/2006 | CN1826346A N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 08/30/2006 | CN1272324C Novel herbicides |
| 08/30/2006 | CN1272322C Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 08/30/2006 | CN1272313C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 08/30/2006 | CN1272105C Catalysts comprising N-substituted cyclic imides and processes for preparing organic compounds with catalysts |
| 08/29/2006 | USRE39251 E.g., 7,11-Di(hydroxy)-8,8,10,12,16-pentamethyl-3-(1-methyl-2-(methylthiazol-4-yl)ethenyl)-4-aza-17-oxabicyclo(14.1.0)heptadecane-5,9-dione, preferably Form A; anticarcinogenic, -proliferative, -diabetic, -inflammatory agents; viricides; autoimmune diseases; psoriasis; agents; cardiovascular disorders |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7097995 Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes |
| 08/29/2006 | CA2280905C Highly lipophilic camptothecin derivatives |
| 08/29/2006 | CA2268195C Azaheterocyclylmethyl derivatives of 2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one |
| 08/29/2006 | CA2239814C Process for the preparation of galanthamine |
| 08/29/2006 | CA2201785C New carboxylic acid derivatives, their preparation and their use |
| 08/24/2006 | WO2006088949A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase |
| 08/24/2006 | WO2006078891A3 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives |
| 08/24/2006 | WO2006075925A3 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide |
| 08/24/2006 | WO2006072818A3 Process for preparation of galanthamine |
| 08/24/2006 | WO2006056850A3 Chroman compounds |
| 08/24/2006 | WO2006046096A3 A polymorphic form of narwedine and its use in the synthesis of galantamine |
| 08/24/2006 | WO2006017822A3 Quinazoline derivatives and their use in the treatment of thrombocythemia |